Canada markets closed

PaxMedica, Inc. (PXMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5100-0.0250 (-4.67%)
At close: 04:00PM EDT
0.5100 0.00 (0.00%)
After hours: 04:11PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.5350
Open0.5110
Bid0.4843 x 100
Ask0.5658 x 100
Day's Range0.5100 - 0.5512
52 Week Range0.3720 - 40.3920
Volume90,321
Avg. Volume251,611
Market Cap3.778M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-11.0000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
  • GlobeNewswire

    PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments

    TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the release of its latest company presentation. This comprehensive overview showcases PaxMedica’s strategic direction, recent advancements in ASD therapeutics, and its commitment to addressing unmet needs within the ASD community. Click here to view the presentation. The new presentation, available

  • ACCESSWIRE

    PaxMedica Releases Fireside Chat Video with CEO Howard Weisman

    TARRYTOWN, NY / ACCESSWIRE / December 6, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, announced the release of a Fireside Chat video featuring Howard Weisman, Chairman ...

  • ACCESSWIRE

    PaxMedica Announces Closing of $7.0 Million Public Offering

    TARRYTOWN, NY / ACCESSWIRE / November 22, 2023 / PaxMedica, Inc. (NASDAQ:PXMD) ("PaxMedica" or the "Company"), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the closing of its previously announced ...